FILTER

Refine your search with the following facets to narrow down your results.

9 Current news of Argenta Discovery

Galapagos acquires Cangenix, a structure-based drug discovery company

18-Jan-2013 - Galapagos NV (GLPG) and Cangenix Ltd announced that Galapagos has acquired Cangenix to add structure-based drug discovery to the Argenta service offering. Under the terms of the acquisition agreement, Galapagos will pay a total cash consideration of £1 million, with a further £440,000 potential ...

acquisitions Galapagos

BioFocus and Argenta Announce Drug Discovery Collaboration with AstraZeneca in Respiratory and Inflammatory Disease

15-Mar-2012 - Galapagos’ service companies, BioFocus and Argenta, announced they have entered into a multi-year collaboration agreement with AstraZeneca to find new compounds against key targets of interest to AstraZeneca’s research programs in respiratory and inflammatory diseases. Under the terms of the ...

AstraZeneca BioFocus DPI collaborations +3

Argenta signs integrated services agreement with Pulmagen Therapeutics

07-Jul-2011 - Galapagos NV announced that service division Argenta has signed a subcontracting agreement with Pulmagen Therapeutics Limited to perform integrated services on two respiratory projects. Under the terms of the agreement, Argenta will be eligible to receive up to £6 million (€7 million) in ...

Galapagos respiratory diseases

Argenta Announces Integrated Drug Discovery Collaboration with Dr. Reddy's Laboratories Ltd

12-Jan-2011 - Argenta announced that it has entered into a drug discovery collaboration with Dr. Reddy's Laboratories Ltd. in the area of pain and inflammation. Argenta will apply its integrated drug discovery platform and expertise for hit-to-lead and lead optimization on multiple Dr. Reddy's discovery ...

cooperations drug discovery

Argenta delivers preclinical candidate for Wellcome Trust funded, anti-aging project

20-Oct-2010 - Argenta, a service division of Galapagos NV, announced that it recently concluded contract research support to the University of Edinburgh for a Wellcome Trust funded Seeding Drug Discovery Initiative (SDDI) project resulting in the successful identification of a preclinical candidate. The ...

clinical trials contract research Enzyme +3

Galapagos' affiliate Argenta and Janssen Pharmaceutica enter in integrated cancer drug discovery service agreement

05-Oct-2010 - Galapagos NV announced that its affiliate, Argenta Discovery 2009 Limited, has entered into a drug discovery service agreement with Janssen Pharmaceutica N.V. (Janssen), aimed at delivering novel cancer drug candidates. Argenta will provide medicinal chemistry and biology for a number of Janssen ...

biology Galapagos medicinal chemistry +2

Argenta expands collaboration with Genentech to include BioFocus

14-Sep-2010 - Argenta, a service division of Galapagos NV, announced it has signed a contract extension with Genentech, Inc., a member of the Roche Group. The extended agreement expands the portfolio of projects which are in collaboration with Genentech and allows Genentech to place projects directly into ...

drug design Galapagos Genentech +3

Galapagos acquires Argenta Discovery's service operations

04-Feb-2010 - Galapagos NV announced the acquisition of Argenta Discovery 2009 Ltd., a privately held contract research drug discovery company with 140 employees. The combination with Galapagos' service division BioFocus creates a drug discovery service organizations with 390 employees, an estimated €70 ...

biology computational chemistry contract research +4

Painceptor Pharma announces collaboration with Argenta Discovery

03-May-2006 - PainCeptor Pharma Corp. announced that it has entered into a development collaboration with Argenta Discovery Ltd., a contract and respiratory drug development company. Under the terms of the agreement, scientists from the two companies will exploit Argenta's expertise in computer-aided drug ...

arthritis drug design drug development +3